ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 157 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,101,932 | -5.8% | 1,401,288 | -0.2% | 0.00% | – |
| Q2 2023 | $2,231,742 | +52.7% | 1,403,611 | -31.1% | 0.00% | – |
| Q1 2023 | $1,461,739 | +5.3% | 2,037,550 | -14.9% | 0.00% | – |
| Q4 2022 | $1,387,789 | -54.3% | 2,394,806 | -25.1% | 0.00% | – |
| Q3 2022 | $3,038,000 | -23.8% | 3,198,725 | -3.8% | 0.00% | – |
| Q2 2022 | $3,988,000 | -58.4% | 3,323,843 | -54.6% | 0.00% | – |
| Q1 2022 | $9,583,000 | -25.9% | 7,315,539 | -0.4% | 0.00% | – |
| Q4 2021 | $12,930,000 | -19.9% | 7,346,822 | -1.2% | 0.00% | – |
| Q3 2021 | $16,134,000 | -42.3% | 7,435,074 | -6.9% | 0.00% | -100.0% |
| Q2 2021 | $27,941,000 | -60.8% | 7,983,122 | +10.5% | 0.00% | -50.0% |
| Q1 2021 | $71,225,000 | -6.7% | 7,223,490 | +2.6% | 0.00% | 0.0% |
| Q4 2020 | $76,343,000 | +9.0% | 7,042,768 | +3.5% | 0.00% | -33.3% |
| Q3 2020 | $70,062,000 | -43.2% | 6,802,150 | +15.1% | 0.00% | -40.0% |
| Q2 2020 | $123,416,000 | +150.4% | 5,910,684 | +17.2% | 0.01% | +150.0% |
| Q1 2020 | $49,285,000 | -5.3% | 5,044,527 | +11.6% | 0.00% | 0.0% |
| Q4 2019 | $52,051,000 | +116.7% | 4,518,433 | +2.5% | 0.00% | +100.0% |
| Q3 2019 | $24,015,000 | -53.0% | 4,406,513 | +2.5% | 0.00% | -50.0% |
| Q2 2019 | $51,116,000 | +125.8% | 4,299,141 | -0.5% | 0.00% | +100.0% |
| Q1 2019 | $22,634,000 | +61.7% | 4,319,670 | -2.8% | 0.00% | 0.0% |
| Q4 2018 | $14,000,000 | -37.3% | 4,443,970 | +20.4% | 0.00% | 0.0% |
| Q3 2018 | $22,326,000 | +27.4% | 3,690,235 | +11.6% | 0.00% | 0.0% |
| Q2 2018 | $17,528,000 | +336.1% | 3,307,449 | +377.4% | 0.00% | – |
| Q1 2018 | $4,019,000 | +187.9% | 692,792 | +73.7% | 0.00% | – |
| Q4 2017 | $1,396,000 | -3.3% | 398,817 | +0.9% | 0.00% | – |
| Q3 2017 | $1,443,000 | +70.8% | 395,209 | +16.9% | 0.00% | – |
| Q2 2017 | $845,000 | -77.8% | 337,966 | -76.0% | 0.00% | – |
| Q1 2017 | $3,798,000 | +23637.5% | 1,406,468 | +26472.2% | 0.00% | – |
| Q4 2016 | $16,000 | -30.4% | 5,293 | -3.0% | 0.00% | – |
| Q3 2016 | $23,000 | +64.3% | 5,454 | +22.5% | 0.00% | – |
| Q2 2016 | $14,000 | – | 4,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |